Seattle Genetics (SGEN) To Offer 9M Shares

Seattle Genetics, Inc. (Nasdaq: SGEN) is offering to sell, subject to market and other conditions, 9,000,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.

All of the shares in the offering are to be sold by Seattle Genetics. J.P. Morgan Securities Inc. and Goldman, Sachs & Co. are acting as joint book-running managers of the proposed offering.